BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30429477)

  • 21. Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
    Allard MA; Saffroy R; de la Maisonneuve PB; Ricca L; Bosselut N; Hamelin J; Lecorche E; Bejarano MA; Innominato P; Sebagh M; Adam R; Morère JF; Lemoine A
    Target Oncol; 2015 Sep; 10(3):415-21. PubMed ID: 25420993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and analysis of microsatellite instability in resected pulmonary metastases from colorectal carcinoma.
    Melloni G; Doglioni C; Bandiera A; Carretta A; Ciriaco P; Arrigoni G; Zannini P
    Ann Thorac Surg; 2006 Jun; 81(6):2008-13. PubMed ID: 16731121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
    Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
    J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis.
    Lee JH; Ahn BK; Baik SS; Lee KH
    In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
    Agarwal E; Robb CM; Smith LM; Brattain MG; Wang J; Black JD; Chowdhury S
    Oncogene; 2017 Jun; 36(22):3104-3118. PubMed ID: 28068324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
    Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway.
    Xing Y; Ren S; Ai L; Sun W; Zhao Z; Jiang F; Zhu Y; Piao D
    Int J Oncol; 2019 May; 54(5):1691-1703. PubMed ID: 30816443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the "Metastasome": Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences.
    Allgayer H; Leupold JH; Patil N
    Semin Cancer Biol; 2020 Feb; 60():1-13. PubMed ID: 31362074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TUC.338 promotes invasion and metastasis in colorectal cancer.
    Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
    Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway.
    Ma Q; Lu Y; Gu Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819841433. PubMed ID: 30947633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO.
    Sonoshita M; Itatani Y; Kakizaki F; Sakimura K; Terashima T; Katsuyama Y; Sakai Y; Taketo MM
    Cancer Discov; 2015 Feb; 5(2):198-211. PubMed ID: 25432929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
    Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
    Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer.
    Qiu J; Compagnone M; Laibe S; Lagarde A; Goncalves A; Turrini O; Xerri L; Monges G; Olschwang S
    Cancer Genomics Proteomics; 2011; 8(1):15-8. PubMed ID: 21289333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncosuppressor methylation: a possible key role in colon metastatic progression.
    Tommasi S; Pinto R; Petriella D; Pilato B; Lacalamita R; Santini D; Zito F; Colucci G; Paradiso A; Silvestris N
    J Cell Physiol; 2011 Jul; 226(7):1934-9. PubMed ID: 21506124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.